E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/16/2005 in the Prospect News Biotech Daily.

SFBC reiterated at hold by Jefferies

SFBC International Inc. was reiterated by Jefferies & Co. Inc. at a hold rating after the company released positive results of an independent investigation of ethics allegations in recent news articles. Jefferies estimates were changed on updated guidance provided by the company. Fourth quarter earnings per share were estimated at $0.48 to $0.53 a share. Consensus is $0.48, Jefferies said, adding that it is not confident that business losses are contained and visibility is extremely low. Shares of the Miami drug research services company were down $2.64, or 16.73% at $13.14 on volume of 14,186,524 shares versus the three-month running average of 1,607,880 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.